NCT07532083 Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery
| NCT ID | NCT07532083 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Oncology |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2026-02-01 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The implementation of the AI-assisted radiology summary tool into clinical workflows is being conducted as part of a standard-of-care quality improvement (QI) initiative at UW Health. The evaluation of this tool's impact via structured feedback from patients and providers is being undertaken as a prospective research study.
Eligibility Criteria
Inclusion Criteria (Patient Participants): * Age 18 years or older * Having a current or prior cancer diagnosis (any cancer type) * Has active access to the UW Health MyChart patient portal. * Receiving care at UW Health within the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology. * Undergoing imaging studies (such as CT, MRI, or PET scans) as part of routine cancer care. * Willing and able to complete electronic REDCap surveys. * For interview participation: willing to participate in a 30-45-minute phone or video interview. Inclusion Criteria (Provider Participants): Cancer care providers will be eligible to participate in this study if they meet all of the following criteria: * Faculty physician (MD or DO) practicing in the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology at UW Health. * Involved in reviewing, discussing, or sharing imaging results with patients. * Planned to gain access to the AI-assisted, patient-friendly imaging summary tool as part of clinical implementation. * Willing and able to complete electronic surveys or participate in a brief interview (\~30 minutes). Exclusion Criteria (Patients): * Are unable to provide informed consent due to cognitive impairment or other limitations, as determined by the clinical or study team. * Enrolled in an active interventional clinical trial. Patients on biospecimen, registry, or non-interventional studies are eligible. * For the Patient Interview group only: Patients with radiographic disease progression will be excluded.
Contact & Investigator
Hamid Emamekhoo, MD
PRINCIPAL INVESTIGATOR
UW School of Medicine and Public Health
Frequently Asked Questions
Who can join the NCT07532083 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Oncology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07532083 currently recruiting?
Yes, NCT07532083 is actively recruiting participants. Contact the research team at supportiveoncology@uwcarbone.wisc.edu for enrollment information.
Where is the NCT07532083 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT07532083 clinical trial?
NCT07532083 is sponsored by University of Wisconsin, Madison. The principal investigator is Hamid Emamekhoo, MD at UW School of Medicine and Public Health. The trial plans to enroll 2,000 participants.